Navigation Links
MCG selected as RNA laboratory for worldwide diabetes study
Date:12/17/2007

The Medical College of Georgia Center for Biotechnology and Genomic Medicine has been selected to isolate RNA and DNA from the blood of thousands of children involved in a worldwide study of the causes of type 1 diabetes.

MCG also is enrolling children in the mammoth study that will eventually follow 8,000 at-risk babies from four states and three countries for 15 years, collecting blood every three months as they go.

The TEDDY The Environmental Determinants of Diabetes in the Young study is keeping tabs on many aspects of the childrens lives from emergency room visits to over-the-counter medicines in an effort to identify environmental triggers for diabetes in children with known high-risk genes.

Once you know the risk factors, you can modulate the risk factors to prevent diabetes, says Dr. Jin-Xiong She, center director and Georgia Research Alliance Eminent Scholar in Genomic Medicine.

Dr. She was among the scientists who conceived the idea of TEDDY and successfully applied for National Institutes of Health funding to pursue it in 2003.

He recently was named principal investigator on the additional five-year, $5 million contract to isolate RNA and DNA from the regularly collected blood.

About 20,000 samples already are awaiting the process. The MCG Center developed a robotic automation that processes 96 samples in about two hours compared to the standard of a few samples in about six hours to handle the huge and growing volume.

Gene expression over time is a new area of research, says Dr. She. The newly established infrastructure enables MCG to isolate nucleic acids for similar large-scale studies.

Isolated nucleic acids will be stored at the National Institute of Diabetes and Digestive and Kidney Diseases Repository. TEDDY scientists will eventually analyze the impact of environmental triggers on the bodys basic building blocks with an eye toward identifying biomarkers that giv
'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia  
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
5. Fry Construction Selected for High-Profile Medical Imaging Project
6. Meth Project Advertisements Selected for National Prevention Campaign
7. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
8. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
9. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
10. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
11. CBaySystems Selected to Receive Deloittes 2007 Maryland Technology Fast 50 Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MCG selected as RNA laboratory for worldwide diabetes study
(Date:7/7/2015)... R.I. (PRWEB) , ... July 07, 2015 , ... Summer ... the proper precautions, however, so Amica Insurance is sharing some safety tips. , Jean ... sports and gardening: , Leisure activities/sports, , Start slowly. Going ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is proud to announce ... an anesthesiologist and pain management specialist, will be evaluating and treating patients with orthopedic ... , After receiving his Bachelor of Science in Biology from the University of the ...
(Date:7/7/2015)... ... July 07, 2015 , ... Parents and guardians of ... A Forever Recovery, an open-ended holistic treatment center for drug and alcohol abuse located ... Use and HIV Research has shown a significant increase in the “club drug” use ...
(Date:7/7/2015)... ... , ... FSAstore.com today announced the launch of its sister site ... simple to use, spend and manage HSA funds with innovative tools including an ... to a report by Devenir , approximately 13.8 million Americans have an HSA, ...
(Date:7/7/2015)... ... July 07, 2015 , ... With a new community program in the San ... and announced a new charity campaign to raise funds in support of programs for ... which was created especially to care for the special needs of our soldiers. ...
Breaking Medicine News(10 mins):Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3
... Friday, July 11, at ... 10:00 P.M. (ET/PT), Produced by Reveille and Hosted ... Students Take On the Physical Challenge to Get Into Better Shape, ... The N, the network totally for and,about teens, and the award-winning production company ...
... Initiative, The University of Melbourne in Melbourne Australia will ... to life sciences. , The initiative will develop the ... to life sciences research in the world. , Funding ... State Government, as announced by the Victorian Premier John ...
... set go to lane 1? , Researchers at ... loud sounds and reaction time are reporting findings that may ... Olympics. , Led by Dave Collins, professor of physical ... the loud starter,s pistol at the Olympic Games would allow ...
... June 18 Transcept,Pharmaceuticals, Inc. today announced that ... present at the Jefferies 2nd Annual,Healthcare Conference in ... at 9:30,AM Eastern Time., The presentation will ... About Transcept Pharmaceuticals, Transcept Pharmaceuticals, Inc. ...
... services into consumers, homes, BOSTON and SAN ... Well(TM) today announced the availability of the Online,Healthcare ... to offer online care services to consumers and ... healthcare,providers to make themselves available to consumers for ...
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer and ... it will participate at the Piper,Jaffray Europe Conference ... Dale, President and CEO of ATS Medical will ... http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), Attendance at the conference is ...
Cached Medicine News:Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 2Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 3Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 4Health News:$100 million supercomputing program boosts Australian medical research capacity 2Health News:Sprinters closest to starter pistol have advantage over those farther away, says study 2Health News:Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference 2Health News:American Well Launches the Online Healthcare Marketplace 2Health News:American Well Launches the Online Healthcare Marketplace 3Health News:ATS Medical to Participate at the Piper Jaffray Europe Conference 2
(Date:7/7/2015)... , July 7, 2015 A power morcellator ... has been settled for an undisclosed amount, Bernstein Liebhard ... filed in March 2014 in the U.S. District Court, ... behalf of a widower whose wife had died in ... a hysterectomy that involved the use of a power ...
(Date:7/7/2015)... According to a new market research ... (Consumables, Instrument), Application (Aerobic, Anaerobic, Yeast/ Fungi) & End User ... to 2019", published by MarketsandMarkets, The global Blood Culture Tests ... $2,750.2 Million in 2014 at a CAGR of 7.2% from ... ma rket data T ables and ...
(Date:7/7/2015)... 7, 2015 C,est ... annonce l,acquisition de 20% du Groupe TRB, ... spécialisée dans la fabrication de médicaments et ...      (Logo: http://photos.prnewswire.com/prnh/20150707/232398LOGO) , ... groupes chimiques et pharmaceutiques italiens, qui contrôle, ...
Breaking Medicine Technology:Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4
... BOULDER, Colo. and MONTREAL, Jan. 9 ... Inc. (TSX: MYG) today announced,the enrollment of ... clinical trial (Trial,CL002) evaluating MGCD0103, the Companies, ... combination with,Vidaza(R) (azacitidine for injection), Pharmion,s DNA ...
... Whatever illness it is, it can make you feel ... but it is even more difficult to handle,being sick ... Diabetes Association (ADA), people with,diabetes who develop an illness ... care of their diabetes. Blood glucose levels can increase,or ...
Cached Medicine Technology:Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 2Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 3Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 4Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 5Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 6Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 7Help! I'm Sick. How Do I Handle My Diabetes? 2
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
... AAA Endovascular Graft with the H&L-B One-Shot ... for the endovascular treatment of patients with ... suitable for endovascular repair. The Zenith AAA ... an aneurysm to "seal off" the aneurysm. ...
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v...
... Pneumatic lift assist stirrups are designed to travel ... -30 degrees. They lock tight wherever you release ... and adduction are done at the handle with ... side rail socket. The rotation of system was ...
Medicine Products: